
OnMed Brings Healthcare to Fiesta Mart with New CareStations in Fort Worth and Missouri City
OnMed, the nation’s leading hybrid healthcare tech company, continues to transform the way people access care, with two new OnMed CareStations launching this July at Fiesta Mart locations in Fort Worth and Missouri City. The Fort Worth CareStation is made…

Twist Bioscience Expands Express Delivery for All Gene Fragment Formats
Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today accelerated its Express turnaround time for all Twist Gene Fragments with a turnaround time starting at two business days for…

ICON and Employees Honored as Industry Leaders in Clinical Research, Innovation, and Sustainability
A world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and…

Lewis Capaldi Teams Up With BetterHelp to Offer Fans 734,000 Hours of Free Online Therapy
After two years away from the spotlight, Lewis Capaldi broke the silence and made a courageous return to music with his new single “Survive” – a bold, brave anthem that addresses a challenging period in his career that peaked at Glastonbury in…

CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology
CorFlow Therapeutics AG a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial…

Modivcare Honors DAB Transport for Compassionate Service and Community Health Impact
A technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, proudly recognizes DAB Transport’s outstanding commitment to service central Georgia with compassion and flexibility. Founded in 2020 by Regina Mcrae, a…

Haleon Begins Construction on £130M Global Oral Health Innovation Centre
Haleon Begins Construction on £130M Global Oral Health Innovation Centre This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre…

Sickle Cell Treatment Market 2025–2035: R&D, Regulation & Pipeline Trends
The “Global Sickle Cell Disease Treatment Market: Focus on Type, End User, and Country-Level Analysis – Analysis and Forecast, 2025-2035″ report has been added to ResearchAndMarkets.com’s offering. The global sickle cell disease treatment market is expected to experience substantial growth, driven by the increasing…

Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine
The “Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and Forecast (2021-2031)” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Vaccine market showcased growth at a CAGR of 6.68% during 2021-2024.…

Bradford Health Acquires The Last Resort, Crestone Wellness, and The Chapter House in Texas
Bradford Health Services, a nationally recognized provider of addiction treatment and behavioral healthcare, today announced the acquisition of three Texas-based programs: The Last Resort Recovery Center, Crestone Wellness, and The Chapter House. This marks the second strategic acquisition in less…

Bicycle Therapeutics Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)
Bicycle Therapeutics plc today announced that on July 1, 2025, the Compensation Committee of the company’s Board of Directors granted to eight new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 77,400 ordinary shares. These…

Modella AI Signs Agreement to Advance AI-Powered Oncology Clinical Development
Modella AI, a leader in artificial intelligence for life sciences, today announced a multi-year agreement with AstraZeneca. Under the agreement, Modella AI will provide access to its state-of-the-art multi-modal AI foundation models to AstraZeneca. This agreement aims to harness Modella…

